Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study

Saved in:
Bibliographic Details
Published inBlood Vol. 126; no. 11; pp. 1392 - 1394
Main Authors Kastritis, Efstathios, Gavriatopoulou, Maria, Kyrtsonis, Marie-Christine, Roussou, Maria, Hadjiharissi, Evdoxia, Symeonidis, Argyris, Repoussis, Panagiotis, Michalis, Evridiki, Delimpasi, Sosana, Tsatalas, Konstantinos, Tsirigotis, Panagiotis, Vassou, Amalia, Vervessou, Elina, Katodritou, Eirini, Gika, Dimitra, Terpos, Evangelos, Dimopoulos, Meletios A.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 10.09.2015
Subjects
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Cyclophosphamide - administration & dosage
Dexamethasone - administration & dosage
Disease Progression
Disease-Free Survival
Humans
Middle Aged
Rituximab - administration & dosage
Treatment Outcome
Waldenstrom Macroglobulinemia - drug therapy
Online AccessGet full text

Cover

More Information
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2015-05-647420